Kardiologia polska最新文献

{"title":"New year 2025 in Polish Heart Journal.","authors":"Anetta Undas","doi":"10.33963/v.phj.104617","DOIUrl":"https://doi.org/10.33963/v.phj.104617","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":"83 1","pages":"1-2"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143080293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and prognostic implications of the longitudinal changes of right ventricular systolic function on cardiac magnetic resonance in dilated cardiomyopathy.","authors":"Ewa Dziewięcka, Robert Banyś, Sylwia Wiśniowska-Śmiałek, Mateusz Winiarczyk, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Monika Lisiecka, Jarosław Gąsiorek, Vladyslav Kyslyi, Maja Płazak, Katarzyna Graczyk, Agnieszka Stępień, Natalia Przytuła, Maria Olszowska, Paweł Rubiś","doi":"10.33963/v.phj.102930","DOIUrl":"10.33963/v.phj.102930","url":null,"abstract":"<p><strong>Background: </strong>Although in many patients with dilated cardiomyopathy (DCM), right ventricular systolic dysfunction (RVSD) accompanies left ventricular SD, knowledge about the RVSD prevalence, course, and prognostic significance in DCM remains limited.</p><p><strong>Aims: </strong>We aimed to analyze the prevalence and prognostic significance of longitudinal changes in RV ejection fraction (RVEF) in DCM.</p><p><strong>Methods: </strong>One hundred and two stable DCM patients were included. Heart failure therapy was up-titrated every 3 months, and CMR was performed at baseline and then after 13 (12.2-13.5) months (CMR-1 and CMR-2). RVSD was defined as RVEF <51% in women and <52% in men in CMR-1, while RVEF and LVEF improved if the increase between CMR-1 and CMR-2 was ≥10%. A composite endpoint, including all-cause mortality, heart transplant, left ventricular assistant device, and urgent cardiac hospitalization, was analyzed after 32.6 (26.3-39.4) months.</p><p><strong>Results: </strong>At baseline, RVSD was observed in 76 (75%) patients. Of 66 DCM patients with RVSD who completed CMR-2, 60% experienced an RVEF improvement. All patients without RVSD at baseline maintained normal RV systolic function at 13 months. Baseline RVSD did not affect the composite endpoint (hazard ratio, 1.241; 95% CI, 0.458-3.366; P = 0.67); however, RVEF improvement was independently associated with this outcome (hazard ratio, 0.260; 95% CI, 0.080-0.846; P = 0.03).</p><p><strong>Conclusions: </strong>Three-quarters of DCM patients exhibited RVSD at baseline, and 60% of them experienced an RVEF improvement following proper heart failure therapy up-titration. While no relationship between outcome and RVSD was observed, RVEF improvement was associated with a 75% reduction in the composite outcome.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"62-69"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The 30-day mortality and mortality-related risk factors in the Polish cohort undergoing catheter ablation of the accessory pathway between 2010 and 2020.","authors":"Krzysztof Dubowski, Michał Orczykowski, Ewa Świerżyńska-Wodarska, Piotr Urbanek, Robert Bodalski, Maria Bilińska, Łukasz Szumowski","doi":"10.33963/v.phj.103198","DOIUrl":"10.33963/v.phj.103198","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"73-75"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atrial fibrillation in elderly patients with severe aortic stenosis. Authors' reply.","authors":"Anna Olasińska-Wiśniewska, Tomasz Urbanowicz","doi":"10.33963/v.phj.103458","DOIUrl":"10.33963/v.phj.103458","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"106-107"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term outcomes, mortality predictors, and cardiac-device-related infective endocarditis in patients with surgically corrected valvular versus non-valvular heart failure treated with cardiac resynchronization therapy.","authors":"Ewa Jędrzejczyk-Patej, Michał Mazurek, Radosław Lenarczyk, Adam Sokal, Agnieszka Kotalczyk, Wiktoria Kowalska, Jakub Gumprecht, Jacek Kowalczyk, Patrycja Pruszkowska-Skrzep, Oskar Kowalski, Zbigniew Kalarus","doi":"10.33963/v.phj.103421","DOIUrl":"10.33963/v.phj.103421","url":null,"abstract":"<p><strong>Background: </strong>Little is known about the prognosis in patients with valvular etiology of heart failure (HF) after cardiac surgery treated with cardiac resynchronization therapy (CRT).</p><p><strong>Aims: </strong>We aimed to assess long-term outcomes, mortality predictors, and the risk of cardiac device-related infective endocarditis (CDRIE) in patients with valvular etiology of HF after cardiac surgery treated with CRT.</p><p><strong>Methods: </strong>The study population involved 1059 consecutive patients with CRT implanted between 2002 and 2019 in a tertiary care university hospital in Poland.</p><p><strong>Results: </strong>The studied population was assigned to two groups: 1) the valvular group (n = 74; 7.0%) with HF patients after cardiac surgery treated with CRT, and 2) the non-valvular group (control group, n = 985; 93.0%) that included all other CRT recipients. During the median follow-up of 1661 days (815-2792), all-cause mortality of CRT recipients with valvular versus non-valvular HF did not differ significantly (50% vs. 54.4%; P = 0.46). Also, the risk of CDRIE was not different (2.7% vs. 5.7%; P = 0.28). In multivariable regression analysis, only older age (HR, 1.04; 95% CI, 1.01-1.07; P = 0.02) was identified as an independent predictor of higher mortality in patients with valvular HF treated with CRT.</p><p><strong>Conclusions: </strong>CRT recipients with valvular HF that had been corrected surgically have similar long-term mortality to CRT patients with non-valvular HF etiologies. In both, death rates reach 50% within 4.5 years. The risk of CDRIE is not higher in the valvular versus non-valvular group of CRT recipients, and advanced age appeared to be the only independent mortality predictor in patients with CRT implanted for valvular HF.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"163-170"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In-stent restenosis risk factors following carotid artery stenting. Authors' reply.","authors":"Ahmet Karaduman, Cemalettin Yılmaz, Muhammet Mucahit Tiryaki, Ismail Balaban, Elnur Alizade, Regayip Zehir","doi":"10.33963/v.phj.103460","DOIUrl":"10.33963/v.phj.103460","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"103-104"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How to assess sudden cardiac death risk in hypertrophic cardiomyopathy? Current challenges and future directions.","authors":"Gabrielle Norrish, Małgorzata Niemiec, Juan P Kaski, Katarzyna Mizia-Stec","doi":"10.33963/v.phj.104052","DOIUrl":"10.33963/v.phj.104052","url":null,"abstract":"<p><p>Over the past decade, knowledge about the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM) has advanced significantly. A standard well-recognized approach to risk stratification is based on the fundamental risk factors and SCD risk models that should be incorporated into the shared decision-making process. More detailed analysis including additional indicators, such as reduced left ventricular systolic function, the presence of late gadolinium enhancement, or in some cases genetic variants, may provide valuable insights for intermediate-risk patients, enabling more personalized diagnosis and treatment. Risk stratification remains challenging in specific groups, such as patients who have undergone septal reduction therapy, those taking mavacamten, or those with phenocopies of HCM. The advancement of modern methodologies, including multifactorial approaches supported by artificial intelligence algorithms, offers hope for more precise and individualized SCD risk assessment in HCM patients.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"8-17"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Many faces of Fabry disease: Variable clinical course with typical non-cardiac symptoms and unexpected heart involvement.","authors":"Wojciech Wróbel, Zbigniew Olczak, Ewelina Szymańska, Katarzyna Mizia-Stec","doi":"10.33963/v.phj.102932","DOIUrl":"10.33963/v.phj.102932","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"207-209"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patent foramen ovale closure for stroke prevention.","authors":"Bartosz Czarniak, Krzysztof Kaczmarek, Piotr Jakubowski, Jarosław Drożdż","doi":"10.33963/v.phj.102564","DOIUrl":"10.33963/v.phj.102564","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"191-193"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of echocardiographic indicators of right ventricular dysfunction in predicting 30-day mortality in non-high- -risk patients with acute pulmonary embolism in different variants of the Bova score.","authors":"Jerzy Wiliński, Ositadima Chukwu, Anna Skwarek, Radosław Borek, Michał Medygrał, Julia Chukwu, Katarzyna Stolarz-Skrzypek, Marek Rajzer","doi":"10.33963/v.phj.103453","DOIUrl":"10.33963/v.phj.103453","url":null,"abstract":"<p><strong>Background: </strong>The Bova score is a validated tool for short-term mortality risk stratification in normotensive patients with acute pulmonary embolism (PE). The prognostic value of echocardiographic parameters in this group of patients remains controversial.</p><p><strong>Aims: </strong>We aimed to assess the role of echocardiographic indicators of right ventricular dysfunction in different variants of the Bova score.</p><p><strong>Methods: </strong>Patients with PE confirmed by computed tomography pulmonary angiography had a transthoracic echocardiogram performed during the first day of hospitalization and 30-day follow-up.</p><p><strong>Results: </strong>One hundred eleven consecutive subjects with non-high-risk PE entered the analysis - 55 men (49.6%), at a median age of 69 (58-79) years; 12 patients died during the 30-day follow-up. Among 3 Bova score variants with different echocardiographic criteria used in practice, the original one AD 2014 had the best but, objectively, poor predictive strength - the area under the curve (AUC) of 0.679. The Bova score with the right-to-left ventricle ratio >1 and tricuspid annular plane systolic excursion <16 mm was an even worse indicator (AUC 0.652), whereas the Bova score with free wall longitudinal strain >-19% and Bova 60/60 sign had fair predictability (AUC 0.701 and 0.731, respectively). Still, they were inferior to the simplified Pulmonary Embolism Severity Index (sPESI, AUC - 0.815). The subjects with Bova score variants with points >4 had a higher risk of death (hazard risk of 1.43-1.59) and with an sPESI ≥1 point had a hazard risk of 2.02.</p><p><strong>Conclusions: </strong>Various echocardiographic markers of right ventricular dysfunction within divergent variants of the Bova score yield different prediction strengths but are all inferior to the sPESI score.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":"171-179"},"PeriodicalIF":3.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}